Kwality Pharmaceuticals
KPLNSE

Kwality Pharmaceuticals

₹3,361.10-269.20 (7.42%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
3,327.00
Today’s high
3,634.50
52 week low
1,561.00
52 week high
3,744.00
Open price
3,604.10
Previous close
3,630.30
Live volume
1,13,735
Lower circuit
2,688.90
Upper circuit
4,033.30

Fundamentals

Market Cap
₹3,764Cr
ROE
20.31%
P/E Ratio(TTM)
46.44
EPS(TTM)
78.11
P/B Ratio
11.38
Dividend Yield
0.00%
Industry P/E
37.23
Book Value
318.80
Debt to Equity
0.39
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹163
+3.03%
Profit (Cr)
₹25.62
+1.22%
050100150200
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+46%
3Y CAGR+26%
Profit growthValue
1Y (TTM)+115%
3Y CAGR+52%

About

Established in 1983, Kwality Pharmaceuticals Limited is a prominent Indian pharmaceutical firm focused on providing high-quality medicines to the global market. The company's vision is to expand its global footprint by registering products in new emerging markets and forming strategic partnerships with international companies. Its mission revolves around manufacturing excellence, using robust quality control systems to consistently ensure the safety and efficacy of its products. The firm's business model is predominantly focused on exports, which contribute to more than 95% of the company's revenues. It manufactures a diverse portfolio of over 3000 formulations, covering more than 25 therapeutic areas including oncology, biologics, and complex injectables. Demonstrating its growing global reach, the company exports to over 60 countries and has recently ventured into the Brazilian and EU markets.;
CEO/MD
Ramesh Kumar
Founded in
1983
NSE symbol
KPL

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,978.20
+58.20 (1.18%)
L
    H
    22,514.2930.625.36
    ₹2,560.80
    +31.10 (1.23%)
    L
      H
      19,234.0028.375.36
      ₹7,415.50
      -91.50 (1.22%)
      L
        H
        18,760.75110.621.5
        Natco PharmaNATCOPHARM
        ₹882.40
        +4.90 (0.56%)
        L
          H
          15,721.3713.731.7
          Livesquawk
          Kwality Pharmaceuticals Q1 revenue rose to ₹1.62B from ₹1.15B YoY. This marks a significant year-over-year growth for the company.
          Livesquawk
          Kwality Pharma's Q4 revenue rose to ₹1.6B from ₹1.15B YoY.
          2026
          10
          Aug
          Quarterly Result
          Release date
          19
          May
          Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          11
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks